Uncategorized Archives - Page 60 of 252

FridayNov 12, 2021 1:28 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Embarks on its Most Ambitious Hypertension Clinical Study Yet: HYPER-H21-4

Lexaria has embarked on its HYPER-H21-4 study, its fourth hypertension clinical study, and it's most ambitious yet This study builds on the HYPER-H21-1 and HYPER-H21-2 findings, as well as the HYPER-H21-3 study that is set to begin dosing in mid-November 2021 Lexaria’s goal is to pursue regulatory approval for its proprietary DehydraTECH-CBD for potential use as a treatment for high blood pressure Study protocols are being readied for submission to the IRB, and approval is expected by January 2022 Lexaria Bioscience (NASDAQ: LEXX) has, so far in 2021, embarked on several studies geared towards evaluating its proprietary DehydraTECH(TM) CBD for…

FridayNov 12, 2021 12:49 pm

The Lift & Co. Expo, Canada’s Number One Cannabis Event, Back in Toronto

Metro Toronto Convention Center, North Building 255 Front St W The Lift & Co. Expo, Canada’s number one cannabis event, makes a comeback this year in Toronto. This four-day event promises to be better than ever before, all while educating, connecting, and growing cannabis consumers, professionals, and media. This event will feature over 250 exhibitors and different forward-thinking speakers, movers and shakers within the industry. It promises to offer attendees top-notch educational content, enrich thought leadership from the industry’s brightest minds, and present fun and authentic networking opportunities. The four-day event will have the Lift Cannabis Conference on the first…

FridayNov 12, 2021 8:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Commences Installation of 30 Growing Pods, Produces First Batch of Chocolates at New Sanderson Production Facility

Red White & Bloom has officially entered Phase 2 of an aggressive three-phase expansion plan in Florida Phase 2 involves the installation and commissioning of 30 customized, self-contained growing pods RWB recently received OMMU approval for the first five pods that it subsequently installed and commissioned The company, through its Red White & Bloom Florida LLC subsidiary, produced the first batch of chocolates from the new Sanderson production facility, making substantial progress since launching the greenhouse facility in Apopka in late September Following the early October completion of phase one of a three-phase development strategy that captures Red White &…

WednesdayNov 10, 2021 12:15 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) Files International Patent Application for Treating Neurodegenerative Diseases Using a New Rare Cannabinoid

InMed Pharmaceuticals has filed an international patent application that specifies a rare cannabinoid that may inhibit or slow the progression of neurodegenerative disease and potentially enhance the neuronal function With neurogenerative diseases affecting millions worldwide and the cost of treating patients expected to rise in the future, finding treatments and cures is a matter of increasing urgency InMed’s patent application is a promising start, expanding the company’s patent portfolio, which currently includes twelve patent families InMed Pharmaceuticals (NASDAQ: INM), a global leader in the manufacturing and pharmaceutical development of rare cannabinoids, recently filed a Patent Cooperation Treaty (“PCT”) application, titled…

WednesdayNov 10, 2021 11:24 am

Sugarmade Inc. (SGMD) Looks to Leverage Expertise as It Eyes Projected Double-Digit CAGR Growth

Global cannabis market estimated to reach $19.89 billion in 2021, projected to grow at a CAGR of 27% North America projected to record the highest market share during the forecast period SGMD is expanding role as a central player in growing California cannabis delivery marketplace, developing in-house cannabis production capacity As growing numbers of consumers around the world become more aware of the potential benefits of cannabis, the market is projected to see significant growth. A new report notes that the global cannabis market is estimated to grow at a CAGR of 27.0% from 2021 to 2030 (https://cnw.fm/KHrYH). That anticipated…

MondayNov 08, 2021 1:59 pm

Simply Sonoma Inc. Looking to Establish Strong Presence in Growing CBD Skin-Care Market

The CBD skin-care sector has been projected to reach $1.7 billion by 2025 Market growth has been driven by rising awareness about the benefits of CBD-infused beauty products. Simply Sonoma anticipates releasing an array of face and skin creams, moisturizers and beauty products. Interest in cannabidiol, or CBD, is exploding as the substance has been shown to have myriad benefits. A chemical derived from cannabis, CBD has been included in everything from gummies to dog treats and more. One of the sectors showing impressive potential is skin care, a market that has been projected to reach $1.7 billion by 2025…

MondayNov 08, 2021 11:59 am

Sugarmade Inc. (SGMD) Continues Commitment to Excellence as Cannabis Bill Creates State Regulatory Framework

Assembly Bill 45 provide clarity for the hemp industry and reassures consumers that products are independently tested and labeled properly Bill allows the sale of hemp-derived extracts that comply with testing and labeling standards SGMD, Nug Avenue committed to providing convenient mobile ordering and online access to its exclusive, quality products Keeping in line with its reputation for leading the way forward in cannabis acceptance and legislation, California lawmakers and government officials have approved an historic hemp bill (https://cnw.fm/9RsrZ). The bill — Assembly Bill 45 (AB-45) — creates a comprehensive regulatory framework for the manufacture and sale of hemp-derived products in…

FridayNov 05, 2021 10:51 am

German Cannabis Market Expected to Liberalize Post Election, RYAH Group Inc. (CSE: RYAH) Enters Germany Via Observational Study

German Social Democrat-led coalition expected to liberalize medical cannabis market Analysts predict over one million medical cannabis patients in Germany by 2024, market estimated to reach $8.9 billion by 2028 RYAH entered German market via observational study with Four 20 Pharma GmbH RYAH provides IoT product ecosystem of volume-control devices, medicine-carrying components, mobile applications RYAH ecosystem offers reliable way for researchers and clinicians to develop well-controlled research environments Germany’s recent 2021 election is expected to result in a new political environment via a coalition containing cannabis-positive political factions that aim to liberalize the country’s plant-based medicine market (https://cnw.fm/z1BxY). RYAH Group…

WednesdayNov 03, 2021 1:44 pm

The Cannabis World Congress & Business Exposition (CWCBExpo) Is Set to Headline the New York Cannabis Week; Will Bring Together Hundreds of Businesses from Across the Cannabis Ecosystem

The Cannabis World Congress & Business Exposition (CWCBExpo) will be held in New York between November 4-6, 2021 The conference will feature over 50 expert speakers, in addition to hundreds of exhibitors showcasing the sector’s latest product innovations Recent forecasts have estimated overall US marijuana retail sales to rise from $20 billion in 2020 to $38.4-45.9 billion by 2025 The Cannabis World Congress & Business Exposition (“CWCBExpo”) event is set to be held at New York City’s Javits Convention Center, Hall 3A between 4-6 November 2021. Set to be held during Cannabis Week, a weeklong event taking place between Monday…

WednesdayNov 03, 2021 12:38 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences New Animal Study Evaluating Patented DehydraTECH(TM) Technology’s Efficacy in Reducing/Inhibiting Seizure Activity; Strengthens IP Portfolio

Lexaria recently announced the commencement of EPIL-A21-1, an animal study to evaluate whether DehydraTECH-CBD has similar or superior efficacy in reducing or inhibiting seizure activity compared to FDA-approved seizure drug, Epidiolex The study will also compare DehydraTECH-CBD to generic CBD EPIL-A21-1 has entered early-stage preparatory work, with results expected in Q3 2022 Lexaria received new patent awards in Mexico and Japan, strengthening its IP portfolio to 23 granted patents Lexaria Bioscience (NASDAQ: LEXX), the drug delivery platform innovator behind the disruptive, patented DehydraTECH(TM) technology, recently announced it had commenced an important new animal study, EPIL-A21-1 (https://cnw.fm/iMVe3). EPIL-A21-1, which will be…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized